familymednews.com
Liver cancer death rates jumped 43 percent, according to a report released Tuesday by the Centers for Disease Control and Prevention. The research collected data from adults 25 and older in the United States from 2000 to 2016. During this time, liver cancer rose from the ninth leading cause of cancer death in 2000 to the sixth leading cause of […]
Continue reading »
A study in Molecular Oncology indicates that examining the protein and RNA in leftover materials from routine diagnostic tests for breast cancer may lead to more accurate diagnoses. Using samples from fine needle aspiration from 25 patients with breast cancer and 33 patients with benign lesions, investigators found that such a strategy could distinguish all cancer patient samples from all […]
Continue reading »
(HealthDay)—Higher levels of vitamin D may be protective against breast cancer, according to a study published online June 15 in PLOS ONE. Sharon L. McDonnell, M.P.H., from GrassrootsHealth in Encinitas, Calif., and colleagues examined the relationship between 25-hydroxyvitamin D (25[OH]D concentration and breast cancer risk across a broad range of 25(OH)D concentrations (
Continue reading »
Pancreatic cancer often spreads, forming metastases in the liver or lungs. The prognosis is better for patients with metastases in the lungs. However, the cancer cells’ ability to alter their characteristics and shape influences which organ is affected, as a research team at the Technical University of Munich (TUM) has discovered. Cells in a tissue or tumor establish contacts with […]
Continue reading »
John Ryan is just one of the miracles to emerge from the Johns Hopkins cancer unit in Baltimore. An immunotherapy treatment—highly effective in a minority of patients—saved his life after a lung cancer diagnosis. The retired military nuclear reactor specialist will celebrate his 74th birthday in July, and his battle with cancer illustrates the promises and failures of immunotherapy, a […]
Continue reading »
New methods of studying the evolution of treatment resistance in head and neck cancer are being developed by researchers at the Johns Hopkins Kimmel Cancer Center. The scientists wanted to examine how cancers acquire resistance to treatment over time and whether those changes could be modeled computationally to determine patient-specific timelines of resistance. The research was published by Genome Medicine […]
Continue reading »
Glioma is the most common type of primary malignant brain tumor in the United States; glioblastoma being the most common type of glioma in adults. While sex differences in the incidence and survival rates of glioma were known, researchers had not investigated whether genetic differences based on sex could cast light on potential differences in the risk profile of glioma […]
Continue reading »
A new device under development by a nuclear engineering professor will allow doctors to dispense accurate dosages of a drug made with actinium-225, an isotope that has been shown to be effective in treating—and curing—myeloid leukemia. The device, devised by Assistant Professor Eric Lukosi and fabricated by master’s student William Gerding, is currently in production. Once it is built, it […]
Continue reading »
South African electrician Phiwankosi Mkhize was diagnosed with lung cancer in May last year and told by the hospital to come back for a scan in 15 months. But after just 12 months he died, before having the chance to receive treatment. The 66-year-old’s fate is far from unique in southeastern KwaZulu-Natal province, the country’s second most populous. Hundreds of […]
Continue reading »
A surprising form of cell-to-cell communication in glioblastoma promotes global changes in recipient cells, including aggressiveness, motility, and resistance to radiation or chemotherapy. Paradoxically, the sending cells in this signaling are glioblastoma cells that are undergoing programmed cell death, or apoptosis, according to research by a team at institutes in the United States, Russia and South Korea. The dying cancer […]
Continue reading »